Vitamin D deficiency has been reported in most patients with cystic fibrosis, even in those patients already taking high-doses multivitamin compounds. Hypovitaminosis D (less than 30 ng/ml) is a relevant problem for patients with Cystic Fibrosis.
In order to supplement routinely high doses of vitamin D, it has been designed DKD: 5,000 IU of Vitamin D3, orodispersable film. DKD is an easy-to-take pharmaceutical form that can improve compliance.
DKD is a food for special medical purposes to supplement the daily intake of vitamin D for those patients who have difficulties with intestinal absorption and metabolism of this vitamin.
Absorption occurs via two routes: a part of the formulation is absorbed by the sublingual mucosa and the remaining portion is ingested.
The product must be used under prescription and medical supervision.